NEW DELHI: Access to quitting aids like nicotine gums and lozenges may soon be tightened, raising concerns among experts it could become harder for smokers to quit. The trigger is a recommendation by the Drug Technical Advisory Board (DTAB) to restrict over-the-counter (OTC) access to most nicotine replacement products. The proposal exempts only unflavoured 2-mg nicotine gum and excludes nicotine lozenges (2 mg). Currently, some of these products are available without a licence. The proposed changes could mean fewer options and more hurdles for those trying to quit. Experts say the concerns stem from how addiction works. Nicotine – not the act of smoking – is an addictive substance, and withdrawal symptoms often push users back to cigarettes. Nicotine replacement therapies – gums and lozenges – help manage the symptoms by delivering nicotine without the thousands of harmful chemicals in tobacco smoking that cause cancer and heart disease. But they are not a guaranteed solution. India, with over 1.35 million tobacco-related deaths annually, depends heavily on accessible support for quitting. Experts warn even small barriers can discourage such attempts. The board has proposed safeguards, including a ban on sale to minors. Some experts argue the risk of misuse of nicotine replacement aids may be overstated. Pulmonologist Dr Priyanka Chaudhary Bindroo said, “… Restricting a WHO-approved cessation aid without contemporary evidence is a step backward.”About the AuthorAnuja JaiswalAnuja Jaiswal is a Senior Assistant Editor at The Times of India, with an impressive 18-year career in narrative journalism. She specializes in health and heritage reporting, expertly simplifying complex health information to make it engaging and understandable for readers. Her deep dives into heritage topics are well-researched, resulting in captivating narratives that resonate with her audience. Over the years, she has worked in Chandigarh, Chhattisgarh and West UP, gaining diverse on-ground experience that shapes her storytelling.Read MoreEnd of ArticleFollow Us On Social MediaVideosVikram Misri Holds Key Talks With French FM, Discusses West Asia Conflict, Bilateral TiesMEA Responds As 15 Indian Ships Remain Stranded Amid Trump’s Hormuz BlockadeUS Naval Blockade on Iran: Why Strait of Hormuz Tensions Could Hit India’s Oil, LPG and InflationTCS Nashik In Eye Of Storm As Women Allege Harassment, Conversion Pressure At Workplace’We Have Common Fate’: Iran Envoy Thanks ‘Friend’ India, Responds On Hormuz Toll RowSupreme Court Refuses To Quash CBI Case Against Lalu Yadav In Land-For-Jobs Scam, Trial To ContinueNoida Protests Explained: Pay Gap Rising Costs And Labour Issues Behind The ViolenceTrust Deficit Grows In Ladakh As Activist Sonam Wangchuk Flags Delay In Talks With CentrePatna Posters Push Nishant Kumar As Next Chief Minister Of BiharDelhi To Dehradun In 2.5 Hours? PM To Flag Off India’s New Expressway That Opens New Era Of Speed123PhotostoriesPoila Boishakh 2026: 9 traditional Bengali dishes served on New YearDelhi-Dehradun Expressway: Travel From Delhi To Dehradun In Just 2.5 Hours! Check Top Facts & PhotosFrom Brad Pitt to Baby Dakota Fanning: 7 actors you totally forgot were on ‘Friends’TV’s 6 female protagonists who were ahead of their time: Tulsi Virani, Anupamaa and more5 cities in West India experiencing real estate boom in 2026Baisakhi 2026: Traditional Baisakhi dishes and their cultural importance in the harvest festivalThis small trick can tell you whether you are consuming watermelon or a toxic fruitEnjoyed ‘The Boys’? Here are more must-watch superhero dramas to binge next5 types of soul contracts and how to recognize yoursLearn these powerful life lessons from Guru Gobind Singh based on your number123Hot PicksIran war ceasefirePAN Card application 2026Purple cap winnerOrange cap winnerIPL Points TablePublic holidays April 2026Bank Holidays AprilTop TrendingTS Dost ScheduleIPL Schedule this weekUK Doctors NewsMorgan StanleyTim DavidJasprit BumrahIPL Points TableRohit SharmaSara TendulkarHardik Pandya
NEW DELHI: Access to quitting aids like nicotine gums and lozenges may soon be tightened, raising concerns among experts it could become harder for smokers to quit. The trigger is a recommendation by the Drug Technical Advisory Board (DTAB) to restrict over-the-counter (OTC) access to most nicotine replacement products. The proposal exempts only unflavoured 2-mg nicotine gum and excludes nicotine lozenges (2 mg). Currently, some of these products are available without a licence. The proposed changes could mean fewer options and more hurdles for those trying to quit. Experts say the concerns stem from how addiction works. Nicotine – not the act of smoking – is an addictive substance, and withdrawal symptoms often push users back to cigarettes. Nicotine replacement therapies – gums and lozenges – help manage the symptoms by delivering nicotine without the thousands of harmful chemicals in tobacco smoking that cause cancer and heart disease. But they are not a guaranteed solution. India, with over 1.35 million tobacco-related deaths annually, depends heavily on accessible support for quitting. Experts warn even small barriers can discourage such attempts. The board has proposed safeguards, including a ban on sale to minors. Some experts argue the risk of misuse of nicotine replacement aids may be overstated. Pulmonologist Dr Priyanka Chaudhary Bindroo said, “… Restricting a WHO-approved cessation aid without contemporary evidence is a step backward.”